IBB PAS Repository

Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure

Maciejak, Agata and Kiliszek, Marek and Michalak, Marcin and Tułacz, Dorota and Opolski, Grzegorz and Matlak, Krzysztof and Dobrzycki, Slawomir and Segiet, Agnieszka and Gora, Monika and Burzynska, Beata (2015) Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure. Genome Medicine, 7 (1). pp. 1-15. ISSN 1756-994X

PDF - Published Version


Abstract BACKGROUND: Heart failure (HF) is the most common cause of morbidity and mortality in developed countries. Here, we identify biologically relevant transcripts that are significantly altered in the early phase of myocardial infarction and are associated with the development of post-myocardial infarction HF. METHODS: We collected peripheral blood samples from patients with ST-segment elevation myocardial infarction (STEMI): n = 111 and n = 41 patients from the study and validation groups, respectively. Control groups comprised patients with a stable coronary artery disease and without a history of myocardial infarction. Based on plasma NT-proBNP level and left ventricular ejection fraction parameters the STEMI patients were divided into HF and non-HF groups. Microarrays were used to analyze mRNA levels in peripheral blood mononuclear cells (PBMCs) isolated from the study group at four time points and control group. Microarray results were validated by RT-qPCR using whole blood RNA from the validation group. RESULTS: Samples from the first three time points (admission, discharge, and 1 month after AMI) were compared with the samples from the same patients collected 6 months after AMI (stable phase) and with the control group. The greatest differences in transcriptional profiles were observed on admission and they gradually stabilized during the follow-up. We have also identified a set of genes the expression of which on the first day of STEMI differed significantly between patients who developed HF after 6 months of observation and those who did not. RNASE1, FMN1, and JDP2 were selected for further analysis and their early up-regulation was confirmed in HF patients from both the study and validation groups. Significant correlations were found between expression levels of these biomarkers and clinical parameters. The receiver operating characteristic (ROC) curves indicated a good prognostic value of the genes chosen. CONCLUSIONS: This study demonstrates an altered gene expression profile in PBMCs during acute myocardial infarction and through the follow-up. The identified gene expression changes at the early phase of STEMI that differentiated the patients who developed HF from those who did not could serve as a convenient tool contributing to the prognosis of heart failure.

Item Type:Article
Subjects:R Medicine > R Medicine (General)
Divisions:Department of Genetics
ID Code:989
Deposited By: MSc Agata Maciejak
Deposited On:21 Oct 2015 11:10
Last Modified:21 Oct 2015 11:10

Repository Staff Only: item control page